Trial Outcomes & Findings for Accuracy of Oxygen Saturation (SpO2) Noninvasive Pulse Oximeter Sensor (RD Disposable) Under Motion Conditions (NCT NCT03124784)
NCT ID: NCT03124784
Last Updated: 2018-03-23
Results Overview
Accuracy will be determined by comparing the noninvasive blood oxygen saturation measurement of the pulse oximeter to that obtained from a blood sample and calculating the arithmetic root mean square error (Arms) value. In order to obtain the Arms value, the blood oxygen saturation measurement is subtracted from the pulse oximeter oxygen saturation measurement for a number of samples, the average of this difference is computed as the bias. The standard deviation of the differences is computed as the precision. The square root of the sum of the squares of bias and precision is computed as the Arms Error value.
COMPLETED
NA
27 participants
1-5 hours
2018-03-23
Participant Flow
Participant milestones
| Measure |
RD Disposable Sensors
All subjects are enrolled into the test group and all subjects received the RD Disposable Sensors
|
|---|---|
|
Overall Study
STARTED
|
27
|
|
Overall Study
COMPLETED
|
25
|
|
Overall Study
NOT COMPLETED
|
2
|
Reasons for withdrawal
| Measure |
RD Disposable Sensors
All subjects are enrolled into the test group and all subjects received the RD Disposable Sensors
|
|---|---|
|
Overall Study
Adverse Event
|
1
|
|
Overall Study
Computer/Equip Malfunction
|
1
|
Baseline Characteristics
Accuracy of Oxygen Saturation (SpO2) Noninvasive Pulse Oximeter Sensor (RD Disposable) Under Motion Conditions
Baseline characteristics by cohort
| Measure |
RD Disposable Sensors
n=25 Participants
All subjects are enrolled into the test group and all subjects received the RD Disposable Sensors
RD Disposable Sensors: Noninvasive pulse oximeter sensor
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=93 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
25 Participants
n=93 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=93 Participants
|
|
Sex: Female, Male
Female
|
13 Participants
n=93 Participants
|
|
Sex: Female, Male
Male
|
12 Participants
n=93 Participants
|
|
Race/Ethnicity, Customized
African American
|
7 Participants
n=93 Participants
|
|
Race/Ethnicity, Customized
Asian or Pacific Islander
|
4 Participants
n=93 Participants
|
|
Race/Ethnicity, Customized
Caucasian
|
7 Participants
n=93 Participants
|
|
Race/Ethnicity, Customized
Hispanic
|
7 Participants
n=93 Participants
|
|
Region of Enrollment
United States
|
25 Participants
n=93 Participants
|
PRIMARY outcome
Timeframe: 1-5 hoursPopulation: 2 subjects were excluded from data analysis: one due to adverse event and the other due to equipment malfunction.
Accuracy will be determined by comparing the noninvasive blood oxygen saturation measurement of the pulse oximeter to that obtained from a blood sample and calculating the arithmetic root mean square error (Arms) value. In order to obtain the Arms value, the blood oxygen saturation measurement is subtracted from the pulse oximeter oxygen saturation measurement for a number of samples, the average of this difference is computed as the bias. The standard deviation of the differences is computed as the precision. The square root of the sum of the squares of bias and precision is computed as the Arms Error value.
Outcome measures
| Measure |
RD Disposable Sensors
n=25 Participants
All subjects are enrolled into the test group and all subjects received the RD Disposable Sensors
|
|---|---|
|
SpO2 ARMS of Sensor Under Motion Conditions
|
1.31 % of oxygen saturated hemoglobin
|
Adverse Events
RD Disposable Sensors
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
RD Disposable Sensors
n=27 participants at risk
All subjects are enrolled into the test group and all subjects received the RD Disposable Sensors
|
|---|---|
|
Injury, poisoning and procedural complications
Sensitivity at site of arterial line placement
|
3.7%
1/27 • Number of events 1 • Adverse event data was collected over the course of the study (within 1 month).
|
|
General disorders
Irregular heart rate
|
3.7%
1/27 • Number of events 1 • Adverse event data was collected over the course of the study (within 1 month).
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place